Grace Therapeutics CEO Prashant Kohli acquires 100,000 common shares for $214,000
GRCE•CEO buys additional shares
- Grace Therapeutics CEO Prashant Kohli bought 100,000 common shares at USD 2.14 each.
- Directly held stake rose to 121,357 shares following the purchase.
